Baseline Characteristics and Secondary Medication Adherence Patterns Among Patients Receiving Tafamidis Prescriptions: A Retrospective Analysis Using a National Specialty Pharmacy Dispensing Database

Anuja Roy1 Global HEOR, Patient & Health Impact, Rare Diseases BU, Pfizer Inc, New York, NY, USACorrespondence[email protected]
View further author information

Andrew Peterson2 Department of Pharmacy Practice/Pharmacy Administration, University of the Sciences, Philadelphia, PA, USAView further author information

Nick Marchant1 Global HEOR, Patient & Health Impact, Rare Diseases BU, Pfizer Inc, New York, NY, USAView further author information

Jose Alvir3 Statistical Research and Data Science Center Global Product Development, Pfizer Inc, New York, NY, USAView further author information

Rahul Bhambri4 Medical Affairs, Pfizer Inc, New York, NY, USAView further author information

Jason Lynn4 Medical Affairs, Pfizer Inc, New York, NY, USAView further author information

Darrin Benjumea5 Evidence Strategy, Genesis Research, Hoboken, NJ, USAView further author information

Sapna Prasad6 Clarify Insights Services, Clarify Health Solutions, New York, NY, USAView further author information

Alex O’Brien6 Clarify Insights Services, Clarify Health Solutions, New York, NY, USAView further author information

Yong Chen7 Rare Disease, Pfizer Inc, Collegeville, PA, USAView further author information

Jason Kemner8 Patient & Health Impact, Pfizer Inc, Collegeville, PA, USAView further author information

Bhash Parasuraman8 Patient & Health Impact, Pfizer Inc, Collegeville, PA, USAView further author information

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.